- $4.68bn
- $4.57bn
- $493.63m
Inari Medical Inc expected to post earnings of 1 cent a share - Earnings Preview
Brief: Inari Medical Board Approves A Reduction In Size From Ten To Nine Members
Brief: Inari Medical Announces Preliminary 2023 Revenue
Medical device stocks rise in relief after Wegovy heart benefits data (updated)
Medical device makers rise on relief after Wegovy obesity trial data
Med-tech cos rise as 'several bullets dodged' in Wegovy trial data
Inari Medical Inc reports results for the quarter ended in September - Earnings Summary
Brief: Inari Medical Q3 Revenue USD 126.366 Million Vs. IBES Estimate USD 121.9 Million
Inari Medical Inc expected to post breakeven results a share - Earnings Preview
Inari Medical Inc reports results for the quarter ended in June - Earnings Summary
Brief: Inari Medical Announces PEERLESS II, A Randomized Controlled Trial Evaluating Clinical Outcomes Of The Flowtriever System Vs Anticoagulation
Brief: Inari Medical sees FY revenue USD 478-488 million
Brief: Inari Medical Reports Qtrly Net Loss Per Share $0.04
Inari Medical Inc expected to post a loss of 23 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Aterian, Datadog, Digital Media Solutions
Brief: Flame Study Demonstrates 90% Survival Improvement In High-Risk Pulmonary Embolism With Inari Medical Flowtriever System
U.S. RESEARCH ROUNDUP-Fubotv, Opal Fuels, Revolution Medicines
Brief: Inari Medical Reports Q4 revenue $107.771 Mln
Inari Medical Inc reports results for the quarter ended in December - Earnings Summary